Development
Vicarious Surgical Inc.
RBOT
$7.58
-$0.07-0.92%
NYSE
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -14.91% | -4.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -28.52% | -3.43% | |||
| Operating Income | 28.52% | 3.43% | |||
| Income Before Tax | 16.51% | -2.41% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 16.51% | -2.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 16.51% | -2.41% | |||
| EBIT | 28.52% | 3.43% | |||
| EBITDA | 29.53% | 3.54% | |||
| EPS Basic | 25.99% | 16.16% | |||
| Normalized Basic EPS | 27.18% | 19.60% | |||
| EPS Diluted | 25.99% | 16.16% | |||
| Normalized Diluted EPS | 27.18% | 19.60% | |||
| Average Basic Shares Outstanding | 12.88% | 22.17% | |||
| Average Diluted Shares Outstanding | 12.88% | 22.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||